Solos Endoscopy, Inc. announces that it will launch a new endoscopic instrument line, SteriTAP. Solos' SteriTAP Instruments are designed to be the ultimate sterile "take-apart" endoscopic instruments of their kind and will be marketed and sold worldwide by Solos Endoscopy.
Solos' SteriTAP instruments are also approved to immediately receive the CE Mark, which will allow the product to be marketed in those countries where the CE Mark is required, once Solos Endoscopy receives its proper certifications. According to Reportlinker, the demand for endoscope services is increasing due to an increase in the aging and chronically ill population worldwide. Advancements in endoscopic technologies and inclusion of various types of lighting sources, video cameras, real-time conversion of data into three-dimensional images are also driving this market. Endoscopy procedures have become highly effective in the diagnosis, treatment, and management of cancer patients. Many now consider endoscopy to have become the gold standard for cancer diagnosis and treatment, as well as for many other medical conditions.
There are other reasons that minimally invasive surgical (MIS) procedures like endoscopy are gaining ground in the overall medical arena. Endoscopic procedures, in general, have a lower cost than their counterparts in traditional surgery. In some cases, the patient only needs light sedation as opposed to full anesthesia. Reduced post surgery monitoring time is required for patients undergoing endoscopic procedures. Finally, there is usually a significantly reduced period the patient has to stay in the hospital along with reduced ancillary costs associated with a post-surgical hospital stay.
The SteriTAP Instrument line will be added to the Solos Endoscopy product line assortment.
"Solos continues to invest its resources in developing new endoscopic instruments to offer a greater selection of products for our customers," says Bob Segersten, president of Solos Endoscopy, Inc.